CICON24 will focus on Translating Science into Survival and feature plenaries by the leaders in the field and proffered talks selected from the submitted abstracts.

SUNDAY, SEPTEMBER 8, 2024

Keynote Lecture

  • Cathy Wu, Dana Farber Cancer Institute

Session 1: Neoadjuvant and Platform Trials

  • Tina Cascone, The University of Texas MD Anderson Cancer Center

  • Luis Diaz, Memorial Sloan Kettering Cancer Center

  • Chuck Drake, Janssen

  • Elizabeth Jaffee, Johns Hopkins Medicine

  • Mark Yarchoan, Johns Hopkins Medicine

 Session 2: Multiomic Data Analysis: Searching for Mechanistic Insights (Beyond just atlas-ing)

  • Elana Fertig, Johns Hopkins Medicine

  • Ben Greenbaum, Memorial Sloan Kettering Cancer Center

  • Benjamin Izar, Columbia University

Session 3: Tertiary Lymphoid Aggregates as Regulators of Anti-Cancer Immunity

  • Tullia Bruno, University of Pittsburgh

  • Anna Dimberg, Uppsala University

  • Wolf Hervé Fridman, Cordeliers Research Center, Paris

  • Nir Hacohen, Massachusetts General Hospital

MONDAY, SEPTEMBER 9, 2024

Session 4: Immune Health and Inflammation as Precursors to Cancer (Cancer Interception)

  • Allie Greenplate, University of Pennsylvania

  • Max Krummel, University of California, San Francisco

  • Amanda Lund, New York University

  • Dana Pe’er, Memorial Sloan Kettering Cancer Center

Session 5:  The Role of Myeloid Cells in the Anti-tumor Response            

  • Greg Beatty, University of Pennsylvania

  • Jennifer Guerriero, Brigham and Women’s Hospital / Harvard Medical School

  • Ming Li, Memorial Sloan Kettering Cancer Center

  • Evanthia Roussos-Torres, University of Southern California

Session 6: Panel Discussion
What’s on the Horizon: New Tools, Technologies, and Approaches in Cancer Immunotherapy.  
Moderated by: Dana Pe’er

  • John Marioni, Genentech

TUESDAY, SEPTEMBER 10, 2024

Session 7: Metabolism: Metabolomic Pathways in the Clinic

  • Marina Baretti, Johns Hopkins Medicine

  • Hongbo Chi, St. Jude Children’s Research Hospital

  • Ping-Chih Ho, University of Lausanne

  • Susan Kaech, Salk Institute for Biological Studies

Session 8: Microbiome --> Diet and Microbiome

  • Tal Danino, Columbia University

  • Andrew Y. Koh, University of Texas Southwestern

  • Saman Maleki, Western University

  • Maria Rescigno, Humanitas University, Milano

  • Jennifer Wargo, The University of Texas MD Anderson Cancer Center

WEDNESDAY, SEPTEMBER 11, 2024

 Session 9:  Moving toward personalized therapies: Cellular & Vaccines

  • Vinod Balachandran, Memorial Sloan Kettering Cancer Center

  • Gianpietro Dotti, UNC Lineberger Comprehensive Cancer Center

  • Magnus Essand, Uppsala University

  • Maria Themeli, University of Amsterdam

  • Neeha Zaidi, Johns Hopkins Medicine

Program still in formation.


Conference Co-Chairpersons
Elizabeth M. Jaffee, Johns Hopkins, Baltimore, MD
Guido Kroemer, Gustave Roussy Cancer Center, Villejuif, France
Dana Pe’er, Memorial Sloan Kettering Cancer Center, New York, NY
Özlem Türeci, BioNTech, Mainz, Germany

Committee Members
James P. Allison, University of Texas M.D. Anderson Cancer Center, Houston, TX
Tullia Bruno, University of Pittsburgh, Pittsburgh, PA
Giulia Casorati, IRCCS Ospedale San Raffaele, Milan, Italy
Yvonne Chen, UCLA, Los Angeles, CA
Lisa Derosa, Gustave Roussy Cancer Center, Villejuif, France
Mustafa Diken, TRON-Translational Oncology, Mainz, Germany
Wolf Hervé Fridman, Cordeliers Research Center, Paris, France
Ming Li, Memorial Sloan Kettering Cancer, New York, NY
Johanna Olweus, Oslo University Hospital, Oslo, Norway
Ellen Puré, University of Pennsylvania, Philadelphia, PA
Antonio Sica, IRCCS Humanitas Clinical and Research Centre, Rozzano, Milan, Italy
Gregory Sonnenberg, Weill Cornell Cancer Center, New York, NY